Long-term control of choroidal neovascularization in quiescent congenital toxoplasma retinochoroiditis with photodynamic therapy: 4-year results

International Ophthalmology

Volumn 30, Issue 1, 2010, Pages 51-56

  Neri, Piergiorgio ^a,b   Mercanti, Lucia ^a   Mariotti, Cesare ^a   Salvolini, Simone ^a   Giovannini, Alfonso ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Choroidal neovascularization; Photodynamic therapy; Retinochoroiditis; Toxoplasma

Indexed keywords

VERTEPORFIN;

ADOLESCENT; ADULT; ARTICLE; CHORIORETINITIS; CLINICAL ARTICLE; CONGENITAL TOXOPLASMA RETINOCHOROIDITIS; DISEASE ASSOCIATION; DISEASE CONTROL; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; MEDICAL RECORD; PHOTODYNAMIC THERAPY; SAFETY; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ADOLESCENT; ADULT; CHORIORETINITIS; CHOROID; CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; FOVEA CENTRALIS; HUMANS; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TIME FACTORS; TOXOPLASMA; TOXOPLASMOSIS, OCULAR; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 76449100523     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-008-9291-6     Document Type: Article

References (16)

1. TF Schlaegel Jr JC Weber 1984 The macula in ocular toxoplasmosis Arch Ophthalmol 102 697 698 6721755
2. I Skorska G Soubrane G Coscas 1984 Toxoplasmic choroiditis and subretinal new vessels J Fr Ophtalmol 7 211 218 1:STN:280:DyaL2c3msFyjsA%3D%3D 6205043
3. LS Atmaca T Simsek F Batioglu 2004 Clinical features and prognosis in ocular toxoplasmosis Jpn J Ophthalmol 48 386 391 10.1007/s10384-003-0069-0 10.1007/s10384-003-0069-0 15295668
4. NM Bressler Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group 2001 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report 2 Arch Ophthalmol 119 198 207 1:CAS:528:DC%2BD3MXhsVCkurs%3D 11176980
5. M Mauget-Faysse G Mimoun JM Ruiz-Moreno M Quaranta-El Maftouhi JJ De Laey L Postelmans G Soubrane M Defauchy A Leys 2006 Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis Retina 26 396 403 10.1097/00006982-200604000-00003 10.1097/00006982-200604000- 00003 16603957 (Pubitemid 44197630)
6. Verteporfin in Photodynamic Therapy Study Group 2001 Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2 Am J Ophthalmol 131 541 560 10.1016/S0002-9394(01)00967-9 10.1016/S0002-9394(01)00967-9 (Pubitemid 32427660)
7. Verteporfin in Photodynamic Therapy Study Group 2001 Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. One-year results of a randomized clinical trial-VIP report no. 1 Ophthalmology 108 841 852 10.1016/S0161-6420(01)00544-9 10.1016/S0161-6420(01) 00544-9 (Pubitemid 32374237)
8. Aaberg TM, VOH Study Group (2004) Four-year results of verteporfin therapy for choroidal neovascularization (CNV) secondary to the ocular histoplasmosis syndrome (OHS): second ear of an open-label extension of the VOH Study (EAbstract). Invest Ophthalmol Vis Sci 45: 2278
9. KF Tabbara 1990 Disruption of the choroidoretinal interface by toxoplasmia Eye 4 366 373 2199243
10. JMD Gass 1967 Pathogenesis of disciform detachment of the neuroepithelium. V. disciform macular degeneration secondary to focal choroiditis Am J Ophthalmol 63 661 686
11. CT Friedman DL Knox 1969 Variations in recurrent active toxoplasmic retinochoroiditis Arch Ophthalmol 18 481 493
12. SL Fine SL Owens JA Heller, et al. 1981 Choroidal neovascularization as a late complication of ocular toxoplasmosis Am J Ophthalmol 91 318 322 1:STN:280:DyaL3M7lslCrsw%3D%3D 6163361
13. AM Cotliar AH Friedman 1982 Subretinal neovascularization in ocular toxoplasmosis Br J Ophthalmol 66 524 529 10.1136/bjo.66.8.524 10.1136/bjo.66.8.524 1:STN:280:DyaL383lslamsg%3D%3D 6179535
14. EB Goshorn DL Hoover AW Eller, et al. 1995 Subretinal neovascularization in children and adolescents J Pediatr Ophthalmol Strabismus 32 178 182 1:STN:280:DyaK2MzmtlKnuw%3D%3D 7636699
15. O Bernasconi C Auer CP Herbort 1997 Recurrent toxoplasmic retinochoroiditis. Significance of perilesional satellite dark dots seen by indocyanine green angiography Ocul Immunol Inflamm 5 207 211 10.3109/09273949709116896 1:STN:280:DyaK2svmslGmtQ%3D%3D 9326766
16. S Ben Yahia CP Herbort S Jenzeri K Hmidi S Attia R Messaoud M Khairallah 2008 Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis Int Ophthalmol 28 311 316 10.1007/s10792-008-9218-2 10.1007/s10792-008-9218-2 18401552